This study aims to observe changes in symptoms according to the treatment effect of hypertension for 6 months after Lodient Tab prescription.
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Adults over 19 years of age
2. A person diagnosed with hypertension
3. A person who has been first prescribed Lodient Tab within the past 4 months as of the IRB approval date or is scheduled to be prescribed Lodient Tab
4. A person who voluntarily agreed in writing to this study
You may not be if
1. Pregnant women or nursing mothers
2. Persons subject to prohibition according to the permission of the Lodient Tab
3. Patients who in the judgement of the investigator, were inappropriate to participate in the study
